MedTrace Logo

Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea

NCT01672606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2016-02-29

No results posted yet for this study

Summary

This study describe the effect of partial neuromuscular blockade of rocuronium on the acute hypoxic ventilatory response in patients with OSA before and after 3 month of CPAP treatment.

Conditions

  • OSA
  • Rocuronium
  • Neuromuscular Blockade
  • Hypoxic Ventilatory Response
  • CPAP

Interventions

DRUG

Rocuronium

Partial neuromuscular blockade with rocuronium with a TOF 0.70

Sponsors & Collaborators

  • Malin Jonsson Fagerlund

    lead OTHER

Principal Investigators

  • Malin Jonsson Fagerlund, MD, PhD · Karolinska University Hospital and Karolinska Institutet

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672606 on ClinicalTrials.gov